Compared to Intermittant Claudication Critical Limb Ischemia Is Associated with Elevated Levels of Cytokines.

by Juho Jalkanen, Mikael Maksimow, Maija Hollmén, Sirpa Jalkanen, Harri Hakovirta
Published 2016-01-01

Soluble CD73 in Critically Ill Septic Patients - Data from the Prospective FINNAKI Study.

by Suvi T Vaara, Maija Hollmén, Anna-Maija Korhonen, Mikael Maksimow, Tero Ala-Kokko, Marko Salmi, Sirpa Jalkanen, Ville Pettilä, FINNAKI Study Group
Published 2016-01-01

The influence of dexmedetomidine and propofol on circulating cytokine levels in healthy subjects

by Minna Kallioinen, Annalotta Scheinin, Mikael Maksimow, Jaakko Långsjö, Kaike Kaisti, Riikka Takala, Tero Vahlberg, Katja Valli, Marko Salmi, Harry Scheinin, Anu Maksimow
Published 2019-12-01

Consequences of the Lack of CD73 and Prostatic Acid Phosphatase in the Lymphoid Organs

by Gennady G. Yegutkin, Kaisa Auvinen, Marika Karikoski, Pia Rantakari, Heidi Gerke, Kati Elima, Mikael Maksimow, Ileana B. Quintero, Pirkko Vihko, Marko Salmi, Sirpa Jalkanen
Published 2014-01-01

Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate.

by Heli Elovaara, Teija Huusko, Mikael Maksimow, Kati Elima, Gennady G Yegutkin, Mikael Skurnik, Ulrich Dobrindt, Anja Siitonen, Michael J McPherson, Marko Salmi, Sirpa Jalkanen
Published 2015-01-01

Novel Biomarkers for Diagnosing Periprosthetic Joint Infection from Synovial Fluid and Serum

by Hannes Keemu, MD, Felix Vaura, Anu Maksimow, MD, PhD, Mikael Maksimow, PhD, Aleksi Jokela, Maija Hollmén, PhD, Keijo Mäkelä, MD, PhD
Published 2021-06-01

Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or sev...

by Geoff Bellingan, David Brealey, Jordi Mancebo, Alain Mercat, Nicolò Patroniti, Ville Pettilä, Michael Quintel, Jean-Louis Vincent, Mikael Maksimow, Markku Jalkanen, Ilse Piippo, V. Marco Ranieri
Published 2017-11-01

Distribution and medical impact of loss-of-function variants in the Finnish founder population.

by Elaine T Lim, Peter Würtz, Aki S Havulinna, Priit Palta, Taru Tukiainen, Karola Rehnström, Tõnu Esko, Reedik Mägi, Michael Inouye, Tuuli Lappalainen, Yingleong Chan, Rany M Salem, Monkol Lek, Jason Flannick, Xueling Sim, Alisa Manning, Claes Ladenvall, Suzannah Bumpstead, Eija Hämäläinen, Kristiina Aalto, Mikael Maksimow, Marko Salmi, Stefan Blankenberg, Diego Ardissino, Svati Shah, Benjamin Horne, Ruth McPherson, Gerald K Hovingh, Muredach P Reilly, Hugh Watkins, Anuj Goel, Martin Farrall, Domenico Girelli, Alex P Reiner, Nathan O Stitziel, Sekar Kathiresan, Stacey Gabriel, Jeffrey C Barrett, Terho Lehtimäki, Markku Laakso, Leif Groop, Jaakko Kaprio, Markus Perola, Mark I McCarthy, Michael Boehnke, David M Altshuler, Cecilia M Lindgren, Joel N Hirschhorn, Andres Metspalu, Nelson B Freimer, Tanja Zeller, Sirpa Jalkanen, Seppo Koskinen, Olli Raitakari, Richard Durbin, Daniel G MacArthur, Veikko Salomaa, Samuli Ripatti, Mark J Daly, Aarno Palotie, Sequencing Initiative Suomi (SISu) Project
Published 2014-07-01